本页面由Tiger Trade Technology Pte. Ltd.提供服务

Oric Pharmaceuticals Inc.

10.23
-0.0500-0.49%
盘后10.21-0.0200-0.20%18:36 EDT
成交量:136.25万
成交额:1,399.61万
市值:10.27亿
市盈率:-6.96
高:10.49
开:10.22
低:10.10
收:10.28
52周最高:14.93
52周最低:4.52
股本:1.00亿
流通股本:8,654.55万
量比:0.77
换手率:1.57%
股息:- -
股息率:- -
每股收益(TTM):-1.4700
每股收益(LYR):-1.4747
净资产收益率:-41.27%
总资产收益率:-26.17%
市净率:2.67
市盈率(LYR):-6.94

数据加载中...

2024/08/12

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/12

重要事件披露

Form 8-K - Current report
2024/06/14

重要事件披露

Form 8-K - Current report
2024/05/06

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/06

重要事件披露

Form 8-K - Current report
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

重要事件披露

Form 8-K - Current report
2024/03/11

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/11

重要事件披露

Form 8-K - Current report
2024/03/07

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/13

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/06

关联方拟减持公告

Form 144 - Report of proposed sale of securities
2024/02/01

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/01

SEC问询函

Form CORRESP - Correspondence
2024/01/30

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/26

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/01/22

重要事件披露

Form 8-K - Current report